Real-world adverse events are explored in children and adolescents with Tourette syndrome treated with D2 receptor antagonists, suggesting important clinical considerations.
This study explored real-world adverse events (AEs) in children and adolescents with TS treated with dopamine D2 receptor antagonists/partial agonists (D2RAs).
No takes yet. Share an insight, caveat, or question.
Isaacs et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: